nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Methylprednisolone—psoriatic arthritis	0.142	0.167	CbGbCtD
Lomitapide—ABCB1—Betamethasone—psoriatic arthritis	0.0926	0.108	CbGbCtD
Lomitapide—ABCB1—Prednisolone—psoriatic arthritis	0.0913	0.107	CbGbCtD
Lomitapide—ABCB1—Prednisone—psoriatic arthritis	0.0863	0.101	CbGbCtD
Lomitapide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0853	0.0999	CbGbCtD
Lomitapide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0647	0.0757	CbGbCtD
Lomitapide—CYP3A4—Betamethasone—psoriatic arthritis	0.0555	0.065	CbGbCtD
Lomitapide—CYP3A4—Prednisolone—psoriatic arthritis	0.0547	0.0641	CbGbCtD
Lomitapide—ABCB1—Dexamethasone—psoriatic arthritis	0.0539	0.0631	CbGbCtD
Lomitapide—CYP3A4—Prednisone—psoriatic arthritis	0.0517	0.0605	CbGbCtD
Lomitapide—ABCB1—Methotrexate—psoriatic arthritis	0.0433	0.0507	CbGbCtD
Lomitapide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0323	0.0378	CbGbCtD
Lomitapide—Reaction gastrointestinal—Methotrexate—psoriatic arthritis	0.00234	0.016	CcSEcCtD
Lomitapide—Weight decreased—Auranofin—psoriatic arthritis	0.00229	0.0157	CcSEcCtD
Lomitapide—Haematuria—Auranofin—psoriatic arthritis	0.00215	0.0147	CcSEcCtD
Lomitapide—Eye disorder—Auranofin—psoriatic arthritis	0.00189	0.013	CcSEcCtD
Lomitapide—Hepatomegaly—Prednisolone—psoriatic arthritis	0.00182	0.0124	CcSEcCtD
Lomitapide—Blister—Prednisolone—psoriatic arthritis	0.00178	0.0122	CcSEcCtD
Lomitapide—Epigastric discomfort—Prednisone—psoriatic arthritis	0.00178	0.0122	CcSEcCtD
Lomitapide—Flatulence—Auranofin—psoriatic arthritis	0.00174	0.0119	CcSEcCtD
Lomitapide—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.00167	0.0114	CcSEcCtD
Lomitapide—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00167	0.0114	CcSEcCtD
Lomitapide—Blister—Triamcinolone—psoriatic arthritis	0.00164	0.0112	CcSEcCtD
Lomitapide—Anaemia—Auranofin—psoriatic arthritis	0.00163	0.0112	CcSEcCtD
Lomitapide—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.00152	0.0104	CcSEcCtD
Lomitapide—Hepatomegaly—Betamethasone—psoriatic arthritis	0.00152	0.0104	CcSEcCtD
Lomitapide—Blister—Dexamethasone—psoriatic arthritis	0.00149	0.0102	CcSEcCtD
Lomitapide—Blister—Betamethasone—psoriatic arthritis	0.00149	0.0102	CcSEcCtD
Lomitapide—Rash erythematous—Betamethasone—psoriatic arthritis	0.0014	0.00959	CcSEcCtD
Lomitapide—Rash erythematous—Dexamethasone—psoriatic arthritis	0.0014	0.00959	CcSEcCtD
Lomitapide—Hepatomegaly—Prednisone—psoriatic arthritis	0.00132	0.00903	CcSEcCtD
Lomitapide—Dyspepsia—Auranofin—psoriatic arthritis	0.00127	0.00867	CcSEcCtD
Lomitapide—Decreased appetite—Auranofin—psoriatic arthritis	0.00125	0.00856	CcSEcCtD
Lomitapide—Constipation—Auranofin—psoriatic arthritis	0.00123	0.00842	CcSEcCtD
Lomitapide—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00118	0.00805	CcSEcCtD
Lomitapide—Ecchymosis—Prednisolone—psoriatic arthritis	0.00116	0.00796	CcSEcCtD
Lomitapide—Abdominal pain—Auranofin—psoriatic arthritis	0.00114	0.00778	CcSEcCtD
Lomitapide—Haematemesis—Methotrexate—psoriatic arthritis	0.00112	0.00769	CcSEcCtD
Lomitapide—Ecchymosis—Triamcinolone—psoriatic arthritis	0.00107	0.00732	CcSEcCtD
Lomitapide—Ecchymosis—Methylprednisolone—psoriatic arthritis	0.00107	0.0073	CcSEcCtD
Lomitapide—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00101	0.00692	CcSEcCtD
Lomitapide—Increased appetite—Prednisolone—psoriatic arthritis	0.000993	0.0068	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.000985	0.00674	CcSEcCtD
Lomitapide—Diarrhoea—Auranofin—psoriatic arthritis	0.000984	0.00674	CcSEcCtD
Lomitapide—Dermatitis bullous—Prednisolone—psoriatic arthritis	0.000977	0.00668	CcSEcCtD
Lomitapide—Ecchymosis—Betamethasone—psoriatic arthritis	0.00097	0.00664	CcSEcCtD
Lomitapide—Ecchymosis—Dexamethasone—psoriatic arthritis	0.00097	0.00664	CcSEcCtD
Lomitapide—Vomiting—Auranofin—psoriatic arthritis	0.000915	0.00626	CcSEcCtD
Lomitapide—Increased appetite—Triamcinolone—psoriatic arthritis	0.000914	0.00625	CcSEcCtD
Lomitapide—Increased appetite—Methylprednisolone—psoriatic arthritis	0.000912	0.00624	CcSEcCtD
Lomitapide—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.000898	0.00615	CcSEcCtD
Lomitapide—Dry skin—Prednisolone—psoriatic arthritis	0.000856	0.00586	CcSEcCtD
Lomitapide—Nausea—Auranofin—psoriatic arthritis	0.000855	0.00585	CcSEcCtD
Lomitapide—Ecchymosis—Prednisone—psoriatic arthritis	0.000845	0.00578	CcSEcCtD
Lomitapide—Increased appetite—Dexamethasone—psoriatic arthritis	0.000829	0.00567	CcSEcCtD
Lomitapide—Increased appetite—Betamethasone—psoriatic arthritis	0.000829	0.00567	CcSEcCtD
Lomitapide—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.000826	0.00565	CcSEcCtD
Lomitapide—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.000815	0.00558	CcSEcCtD
Lomitapide—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.000815	0.00558	CcSEcCtD
Lomitapide—Abdominal distension—Prednisolone—psoriatic arthritis	0.000812	0.00556	CcSEcCtD
Lomitapide—Migraine—Dexamethasone—psoriatic arthritis	0.000767	0.00525	CcSEcCtD
Lomitapide—Migraine—Betamethasone—psoriatic arthritis	0.000767	0.00525	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000755	0.00517	CcSEcCtD
Lomitapide—Abdominal distension—Triamcinolone—psoriatic arthritis	0.000747	0.00511	CcSEcCtD
Lomitapide—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.000745	0.0051	CcSEcCtD
Lomitapide—Influenza—Triamcinolone—psoriatic arthritis	0.000742	0.00508	CcSEcCtD
Lomitapide—Increased appetite—Prednisone—psoriatic arthritis	0.000722	0.00494	CcSEcCtD
Lomitapide—Dry skin—Betamethasone—psoriatic arthritis	0.000714	0.00489	CcSEcCtD
Lomitapide—Dry skin—Dexamethasone—psoriatic arthritis	0.000714	0.00489	CcSEcCtD
Lomitapide—Ecchymosis—Methotrexate—psoriatic arthritis	0.000706	0.00483	CcSEcCtD
Lomitapide—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00066	0.00452	CcSEcCtD
Lomitapide—Infestation—Methylprednisolone—psoriatic arthritis	0.00066	0.00452	CcSEcCtD
Lomitapide—Dry skin—Prednisone—psoriatic arthritis	0.000622	0.00425	CcSEcCtD
Lomitapide—Weight decreased—Dexamethasone—psoriatic arthritis	0.000609	0.00417	CcSEcCtD
Lomitapide—Weight decreased—Betamethasone—psoriatic arthritis	0.000609	0.00417	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000598	0.00409	CcSEcCtD
Lomitapide—Abdominal distension—Prednisone—psoriatic arthritis	0.00059	0.00404	CcSEcCtD
Lomitapide—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000582	0.00398	CcSEcCtD
Lomitapide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000554	0.00379	CcSEcCtD
Lomitapide—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00055	0.00376	CcSEcCtD
Lomitapide—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000534	0.00365	CcSEcCtD
Lomitapide—Weight decreased—Prednisone—psoriatic arthritis	0.00053	0.00363	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000523	0.00358	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000522	0.00357	CcSEcCtD
Lomitapide—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000516	0.00353	CcSEcCtD
Lomitapide—Malaise—Prednisolone—psoriatic arthritis	0.000507	0.00347	CcSEcCtD
Lomitapide—Vertigo—Prednisolone—psoriatic arthritis	0.000505	0.00346	CcSEcCtD
Lomitapide—Eye disorder—Dexamethasone—psoriatic arthritis	0.000504	0.00345	CcSEcCtD
Lomitapide—Eye disorder—Betamethasone—psoriatic arthritis	0.000504	0.00345	CcSEcCtD
Lomitapide—Back pain—Triamcinolone—psoriatic arthritis	0.0005	0.00342	CcSEcCtD
Lomitapide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00048	0.00328	CcSEcCtD
Lomitapide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000479	0.00328	CcSEcCtD
Lomitapide—Discomfort—Prednisolone—psoriatic arthritis	0.000473	0.00324	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00047	0.00321	CcSEcCtD
Lomitapide—Malaise—Triamcinolone—psoriatic arthritis	0.000466	0.00319	CcSEcCtD
Lomitapide—Malaise—Methylprednisolone—psoriatic arthritis	0.000465	0.00318	CcSEcCtD
Lomitapide—Vertigo—Triamcinolone—psoriatic arthritis	0.000464	0.00318	CcSEcCtD
Lomitapide—Vertigo—Methylprednisolone—psoriatic arthritis	0.000463	0.00317	CcSEcCtD
Lomitapide—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000461	0.00316	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000443	0.00304	CcSEcCtD
Lomitapide—Myalgia—Triamcinolone—psoriatic arthritis	0.00044	0.00301	CcSEcCtD
Lomitapide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000439	0.00301	CcSEcCtD
Lomitapide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000439	0.00301	CcSEcCtD
Lomitapide—Eye disorder—Prednisone—psoriatic arthritis	0.000438	0.003	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—psoriatic arthritis	0.000437	0.00299	CcSEcCtD
Lomitapide—Infestation—Methotrexate—psoriatic arthritis	0.000437	0.00299	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000436	0.00298	CcSEcCtD
Lomitapide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000435	0.00298	CcSEcCtD
Lomitapide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000435	0.00298	CcSEcCtD
Lomitapide—Discomfort—Triamcinolone—psoriatic arthritis	0.000435	0.00298	CcSEcCtD
Lomitapide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000434	0.00297	CcSEcCtD
Lomitapide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00043	0.00295	CcSEcCtD
Lomitapide—Malaise—Dexamethasone—psoriatic arthritis	0.000423	0.00289	CcSEcCtD
Lomitapide—Malaise—Betamethasone—psoriatic arthritis	0.000423	0.00289	CcSEcCtD
Lomitapide—Vertigo—Dexamethasone—psoriatic arthritis	0.000421	0.00288	CcSEcCtD
Lomitapide—Vertigo—Betamethasone—psoriatic arthritis	0.000421	0.00288	CcSEcCtD
Lomitapide—Infection—Triamcinolone—psoriatic arthritis	0.000419	0.00287	CcSEcCtD
Lomitapide—Infection—Methylprednisolone—psoriatic arthritis	0.000418	0.00286	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—psoriatic arthritis	0.000416	0.00285	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000413	0.00283	CcSEcCtD
Lomitapide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000413	0.00283	CcSEcCtD
Lomitapide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000412	0.00282	CcSEcCtD
Lomitapide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000409	0.0028	CcSEcCtD
Lomitapide—Malnutrition—Prednisone—psoriatic arthritis	0.000408	0.0028	CcSEcCtD
Lomitapide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000408	0.00279	CcSEcCtD
Lomitapide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000407	0.00278	CcSEcCtD
Lomitapide—Myalgia—Betamethasone—psoriatic arthritis	0.000399	0.00273	CcSEcCtD
Lomitapide—Myalgia—Dexamethasone—psoriatic arthritis	0.000399	0.00273	CcSEcCtD
Lomitapide—Discomfort—Dexamethasone—psoriatic arthritis	0.000395	0.0027	CcSEcCtD
Lomitapide—Discomfort—Betamethasone—psoriatic arthritis	0.000395	0.0027	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000387	0.00265	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000384	0.00263	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000384	0.00263	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000383	0.00262	CcSEcCtD
Lomitapide—Infection—Dexamethasone—psoriatic arthritis	0.00038	0.0026	CcSEcCtD
Lomitapide—Infection—Betamethasone—psoriatic arthritis	0.00038	0.0026	CcSEcCtD
Lomitapide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000379	0.00259	CcSEcCtD
Lomitapide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000379	0.00259	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000378	0.00259	CcSEcCtD
Lomitapide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000378	0.00259	CcSEcCtD
Lomitapide—Anaemia—Prednisone—psoriatic arthritis	0.000378	0.00258	CcSEcCtD
Lomitapide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000375	0.00257	CcSEcCtD
Lomitapide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000375	0.00257	CcSEcCtD
Lomitapide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000371	0.00254	CcSEcCtD
Lomitapide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000371	0.00254	CcSEcCtD
Lomitapide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00037	0.00253	CcSEcCtD
Lomitapide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00037	0.00253	CcSEcCtD
Lomitapide—Malaise—Prednisone—psoriatic arthritis	0.000368	0.00252	CcSEcCtD
Lomitapide—Vertigo—Prednisone—psoriatic arthritis	0.000367	0.00251	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—psoriatic arthritis	0.000366	0.00251	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000364	0.00249	CcSEcCtD
Lomitapide—Fatigue—Triamcinolone—psoriatic arthritis	0.000364	0.00249	CcSEcCtD
Lomitapide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000363	0.00248	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000353	0.00242	CcSEcCtD
Lomitapide—Chills—Methotrexate—psoriatic arthritis	0.000352	0.00241	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000349	0.00239	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000349	0.00239	CcSEcCtD
Lomitapide—Arthralgia—Prednisone—psoriatic arthritis	0.000348	0.00238	CcSEcCtD
Lomitapide—Myalgia—Prednisone—psoriatic arthritis	0.000348	0.00238	CcSEcCtD
Lomitapide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000348	0.00238	CcSEcCtD
Lomitapide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000347	0.00237	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000345	0.00236	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000344	0.00236	CcSEcCtD
Lomitapide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000344	0.00235	CcSEcCtD
Lomitapide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000344	0.00235	CcSEcCtD
Lomitapide—Discomfort—Prednisone—psoriatic arthritis	0.000344	0.00235	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—psoriatic arthritis	0.000341	0.00234	CcSEcCtD
Lomitapide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000337	0.00231	CcSEcCtD
Lomitapide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000337	0.00231	CcSEcCtD
Lomitapide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000333	0.00228	CcSEcCtD
Lomitapide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000333	0.00228	CcSEcCtD
Lomitapide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000333	0.00228	CcSEcCtD
Lomitapide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000333	0.00228	CcSEcCtD
Lomitapide—Infection—Prednisone—psoriatic arthritis	0.000331	0.00227	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00033	0.00226	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00033	0.00226	CcSEcCtD
Lomitapide—Back pain—Methotrexate—psoriatic arthritis	0.00033	0.00226	CcSEcCtD
Lomitapide—Fatigue—Betamethasone—psoriatic arthritis	0.00033	0.00226	CcSEcCtD
Lomitapide—Fatigue—Dexamethasone—psoriatic arthritis	0.00033	0.00226	CcSEcCtD
Lomitapide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000327	0.00224	CcSEcCtD
Lomitapide—Skin disorder—Prednisone—psoriatic arthritis	0.000324	0.00222	CcSEcCtD
Lomitapide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000322	0.00221	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000317	0.00217	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—psoriatic arthritis	0.000316	0.00216	CcSEcCtD
Lomitapide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000315	0.00216	CcSEcCtD
Lomitapide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000315	0.00216	CcSEcCtD
Lomitapide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000313	0.00214	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000313	0.00214	CcSEcCtD
Lomitapide—Malaise—Methotrexate—psoriatic arthritis	0.000308	0.00211	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—psoriatic arthritis	0.000307	0.0021	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000304	0.00208	CcSEcCtD
Lomitapide—Dizziness—Prednisolone—psoriatic arthritis	0.000303	0.00208	CcSEcCtD
Lomitapide—Asthenia—Triamcinolone—psoriatic arthritis	0.000303	0.00207	CcSEcCtD
Lomitapide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000303	0.00207	CcSEcCtD
Lomitapide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000303	0.00207	CcSEcCtD
Lomitapide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000303	0.00207	CcSEcCtD
Lomitapide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000303	0.00207	CcSEcCtD
Lomitapide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000302	0.00207	CcSEcCtD
Lomitapide—Paraesthesia—Prednisone—psoriatic arthritis	0.000299	0.00205	CcSEcCtD
Lomitapide—Dyspepsia—Prednisone—psoriatic arthritis	0.000293	0.00201	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—psoriatic arthritis	0.000291	0.00199	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—psoriatic arthritis	0.000291	0.00199	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—psoriatic arthritis	0.000291	0.00199	CcSEcCtD
Lomitapide—Decreased appetite—Prednisone—psoriatic arthritis	0.00029	0.00198	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000289	0.00198	CcSEcCtD
Lomitapide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000288	0.00197	CcSEcCtD
Lomitapide—Fatigue—Prednisone—psoriatic arthritis	0.000287	0.00197	CcSEcCtD
Lomitapide—Headache—Prednisolone—psoriatic arthritis	0.000287	0.00197	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—psoriatic arthritis	0.000287	0.00197	CcSEcCtD
Lomitapide—Constipation—Prednisone—psoriatic arthritis	0.000285	0.00195	CcSEcCtD
Lomitapide—Dizziness—Triamcinolone—psoriatic arthritis	0.000279	0.00191	CcSEcCtD
Lomitapide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000278	0.00191	CcSEcCtD
Lomitapide—Infection—Methotrexate—psoriatic arthritis	0.000277	0.00189	CcSEcCtD
Lomitapide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000275	0.00188	CcSEcCtD
Lomitapide—Asthenia—Betamethasone—psoriatic arthritis	0.000275	0.00188	CcSEcCtD
Lomitapide—Asthenia—Dexamethasone—psoriatic arthritis	0.000275	0.00188	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000273	0.00187	CcSEcCtD
Lomitapide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000273	0.00187	CcSEcCtD
Lomitapide—Nausea—Prednisolone—psoriatic arthritis	0.000272	0.00186	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—psoriatic arthritis	0.000271	0.00185	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000269	0.00184	CcSEcCtD
Lomitapide—Vomiting—Triamcinolone—psoriatic arthritis	0.000268	0.00184	CcSEcCtD
Lomitapide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000268	0.00183	CcSEcCtD
Lomitapide—Headache—Triamcinolone—psoriatic arthritis	0.000264	0.00181	CcSEcCtD
Lomitapide—Headache—Methylprednisolone—psoriatic arthritis	0.000264	0.0018	CcSEcCtD
Lomitapide—Abdominal pain—Prednisone—psoriatic arthritis	0.000264	0.0018	CcSEcCtD
Lomitapide—Body temperature increased—Prednisone—psoriatic arthritis	0.000264	0.0018	CcSEcCtD
Lomitapide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000262	0.00179	CcSEcCtD
Lomitapide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000262	0.00179	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000254	0.00174	CcSEcCtD
Lomitapide—Dizziness—Dexamethasone—psoriatic arthritis	0.000253	0.00173	CcSEcCtD
Lomitapide—Dizziness—Betamethasone—psoriatic arthritis	0.000253	0.00173	CcSEcCtD
Lomitapide—Nausea—Triamcinolone—psoriatic arthritis	0.000251	0.00172	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—psoriatic arthritis	0.00025	0.00171	CcSEcCtD
Lomitapide—Nausea—Methylprednisolone—psoriatic arthritis	0.00025	0.00171	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—psoriatic arthritis	0.000248	0.0017	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000245	0.00168	CcSEcCtD
Lomitapide—Vomiting—Dexamethasone—psoriatic arthritis	0.000243	0.00167	CcSEcCtD
Lomitapide—Vomiting—Betamethasone—psoriatic arthritis	0.000243	0.00167	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000242	0.00166	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000241	0.00165	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—psoriatic arthritis	0.00024	0.00164	CcSEcCtD
Lomitapide—Headache—Betamethasone—psoriatic arthritis	0.00024	0.00164	CcSEcCtD
Lomitapide—Headache—Dexamethasone—psoriatic arthritis	0.00024	0.00164	CcSEcCtD
Lomitapide—Asthenia—Prednisone—psoriatic arthritis	0.000239	0.00164	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00023	0.00157	CcSEcCtD
Lomitapide—Diarrhoea—Prednisone—psoriatic arthritis	0.000228	0.00156	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000228	0.00156	CcSEcCtD
Lomitapide—Nausea—Betamethasone—psoriatic arthritis	0.000227	0.00156	CcSEcCtD
Lomitapide—Nausea—Dexamethasone—psoriatic arthritis	0.000227	0.00156	CcSEcCtD
Lomitapide—Dizziness—Prednisone—psoriatic arthritis	0.00022	0.00151	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00022	0.00151	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00022	0.00151	CcSEcCtD
Lomitapide—Vomiting—Prednisone—psoriatic arthritis	0.000212	0.00145	CcSEcCtD
Lomitapide—Headache—Prednisone—psoriatic arthritis	0.000209	0.00143	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—psoriatic arthritis	0.0002	0.00137	CcSEcCtD
Lomitapide—Nausea—Prednisone—psoriatic arthritis	0.000198	0.00136	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000191	0.0013	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—psoriatic arthritis	0.000184	0.00126	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—psoriatic arthritis	0.000177	0.00121	CcSEcCtD
Lomitapide—Headache—Methotrexate—psoriatic arthritis	0.000175	0.00119	CcSEcCtD
Lomitapide—Nausea—Methotrexate—psoriatic arthritis	0.000165	0.00113	CcSEcCtD
